Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells

Hepatology

Volumn 26, Issue 2, 1997, Pages 315-322

  Préaux, Anne Marie ^a   Mallat, Ariane ^a   Rosenbaum, Jean ^a,b   Zafrani, Elie Serge ^a   Mavier, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GELATINASE A; PENTOXIFYLLINE;

ARTICLE; AUTORADIOGRAPHY; CELL CULTURE; CELL GROWTH; CHRONIC LIVER DISEASE; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; FIBROGENESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER FIBROSIS; MYOFIBROBLAST; NORTHERN BLOTTING; PRIORITY JOURNAL; STELLATE CELL;

CELL DIVISION; CELLS, CULTURED; COLLAGEN; GELATINASES; HUMANS; LIVER; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; PENTOXIFYLLINE;

EID: 0030795195     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260210     Document Type: Article

References (24)

1. Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991;138:1233-1242.
2. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-1835.
3. Gressner AM. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem 1991;29:293-311.
4. Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. HEPATOLOGY 1988;8:1027-1033.
5. Ogawa K, Suzuki JI, Mukai H, Mori M. Sequential changes of extracellular matrix and proliferation of Ito cells with enhanced expression of desmin and actin in focal hepatic injury. Am J Pathol 1986;125:611-619.
6. Miyazaki H, Van Eyken P, Roskams T, De Vos R, Desmet VJ. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. J Hepatol 1993;19:353-366.
7. Tang L, Tanaka Y, Marumo F, Sato C. Phenotypic change in portal fibroblasts in biliary fibrosis. Liver 1994;14:76-82.
8. Milani S, Herbst H, Schuppan D, Riecken EO, Stein H. Cellular localization of laminin gene transcripts in normal and fibrotic human liver. Am J Pathol 1989;134:1175-1182.
9. Milani S, Herbst H, Schuppan D, Surrenti C, Riecken EO, Stein H. Cellular localization of type I, III and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol 1990;137:59-70.
10. Takahara T, Nakayama Y, Itoh H, Miyabayashi C, Watanabe A, Sasaki H, Inoue K, et al. Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study. Liver 1992;12:368-380.
11. Grimaud JA, Druguet M, Peyrol S, Chevalier O, Herbage D, El Badrawy N. Collagen immunotyping in human liver: light and electron microscope study. J Histochem Cytochem 1980;28:1145-1156.
12. Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut 1980;21:63-71.
13. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990;10:1-10.
14. Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994;144:528-537.
15. Arthur MJP, Stanley A, Iredale JP, Rafferty JA, Hembry RM, Friedman SL. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J 1992;287:701-707.
16. Murphy G, McAlpine CG, Poll CT, Reynolds JJ. Purification and charac-terization of a bone metalloproteinase that degrades gelatin and type IV and V collagens. Biochim Biophys Acta 1985;831:49-58.
17. Guerrini M, Pecchi S, Rossi C, Capelli R, Pieragalli D, Acciavatti A. Effects of pentifylline on blood hyperviscosity and peripheral hemodynamic in patients with peripheral obliterating arterial disease. Pharmatherapeutica 1983;3(Suppl 1):52-66.
18. Berman B, Duncan MR. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol 1989;92:605-610.
19. Berman B, Duncan MR. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol 1990;123:339-346.
20. Chang CC, Wu YC, Chiu HC, Liu YL, Lu YC. Pentoxifylline inhibits the proliferation of human fibroblasts derived from normal, hypertrophie scar and cheloid skin and their mitochondrial activity and collagen synthesis. Eur J Dermatol 1991;1:214-220.
21. 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. HEPATOLOGY 1993;18:137-145.
22. Blazejewski S, Préaux AM, Mallat A, Brocheriou I, Mavier P, Dhumeaux D, Hartmann D, et al. Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver. HEPATOLOGY 1995;22:788-797.
23. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-277.
24. Mallat A, Préaux AM, Blazejewski S, Dhumeaux D, Rosenbaum J, Mavier P. Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. HEPATOLOGY 1994;20:1589-1594.